Document is current
Any future updates will be listed below
-
Authors
Kimber, Catherine
Malouf, Reem
Javan, Javad
Dorée, Carolyn
Howe, Elaine
McDonald, Vickie
Leite, M Isabel
Rinaldi, Simon
Tsiachristas, Apostolos
Desborough, Michael
Estcourt, Lise
-
Funding
Funding for this research was provided by:
NHS Blood and Transplant (NHSBT Small Grant Award 2024-2025 for Health economic. Grant ref:148TRAN24)
- License Information
-
More Information
Article History
Received: 15 December 2025
Accepted: 26 February 2026
First Online: 7 March 2026
Declarations
:
: Not applicable.
: Not applicable.
: AT and JJ acknowledge funding support from the National Institute for Health and Care Research (NIHR) HealthTech Research Centre (HRC) Community Healthcare, and the NIHR Applied Research Collaboration (ARC) Oxford and Thames Valley. AT also acknowledges support from the NIHR Oxford Health Biomedical Research Centre. Funding received from NHSBT Small Grant Award. 2024 to ‘25 for Health economic. Grant Reference 148TRAN24. Systematic review including health economic assessment of the benefits of Intravenous immunoglobulin versus therapeutic apheresis for neurological conditions (the “Project”) £73,659. No funders were involved with search, data collection, writing or decision to submit for publication. No funders were involved with search, data collection, writing or decision to submit for publication.
